PubMed HealthSearch

PubMed · 1047989

Multidrug-resistant Proteus rettgeri: an emerging problem.

Abstract

The recent development of multidrug-resistant strains of Proteus rettgeri prompted a 6-year review of infections with this organism. Ninety percent of infections involved the urinary tract. Fifty percent of infections occurred on the neurology ward, where a progressive annual increase in attack rate was noted. Statistically significant (P less than 0.005) increases in total length of hospitalization, length of hospitalization before infection, presence and duration of indwelling Foley catheterization, prior exposure to antibiotics, and the prevalence of paraplegia were present in P. rettgeri urinary tract infections as compared with a control group. A progressive increase in resistance to kanamycin, streptomycin, ampicillin, and gentamicin occurred during 6 years. Disc diffusion sensitivities of recent isolates show total resistance to commonly tested antibiotics. Eighty percent or more of strains are inhibited, however, by 3.13 mug/ml of amikacin and cefoxitin, and 0.4 mug/ml of ticarcillin.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P B Iannini, T C Eickhoff, F M LaForce. 1976. Multidrug-resistant Proteus rettgeri: an emerging problem.. https://doi.org/10.7326/0003-4819-85-2-161

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Investigation of in vitro susceptibility and resistance mechanisms to amikacin among diverse carbapenemase-producing Enterobacteriaceae.

OBJECTIVE: This study aims to assess the in vitro drug susceptibility of various Carbapenemase-Producing Enterobacteriaceae (CPE) genotypes and elucidate the underlying mechanisms of amikacin resistance. METHODS: A total of 72 unique CPE strains were collected from the Second Hospital of Jiaxing between 2019 and 2022, including 51 strains of Klebsiella pneumoniae, 11 strains of Escherichia coli, 6 strains of Enterobacter cloacae, 2 strains of Klebsiella aerogenes, 1 strain of Citrobacter freundii, and 1strain of Citrobacter werkmanii. Among these strains, 24 carried blaKPC gene, 20 carried blaNDM gene, 23 carried blaOXA-48-like gene, and 5 carried both blaKPC and blaNDM. We measured the in vitro activity of amikacin and other common antibiotics. Strains carrying blaOXA-48-like gene were selected for whole genome sequencing (WGS) via next-generation sequencing to identify genes related to antimicrobial resistance (AMR) and virulence factor (VF). RESULTS: Out of the 72 CPE strains tested, 41.7% exhibited resistance to amikacin. The drug resistance rates for K. pneumoniae, E. coli, and Enterobacter spp. were 51.0%, 27.3%, and 10.0%, respectively. The majority of the CPE strains (>&#x2009;90%) displayed resistance to cephalosporins and carbapenems, while most of them were sensitive to polymyxin B and tigecycline (97.2% and 94.4%). The amikacin resistance rate was 100% for strains carrying blaOXA-48, 20.8% for those with blaKPC, 5.0% for those with blaNDM, and 20.0% for those with both blaKPC and blaNDM. These differences were statistically significant (P&#x2009;<&#x2009;0.05). Through sequencing, we detected aminoglycoside resistance genes rmtF and aac(6')-Ib, VF genes iucABCD and rmpA2 in OXA-48-producing multidrug resistance and highly virulent strains. These genes were located on a IncFIB- and IncHI1B-type plasmid, respectively. Both plasmids were highly homologous to the plasmid from OXA-232 strains in Zhejiang province and Shanghai province. Integration of these resistance genes into the IncFIB plasmid, facilitated by the IS6 and/or Tn3 transposons, resulted in OXA232-producing K. pneumoniae with amikacin resistance. CONCLUSION: This study identified significant amikacin resistance in CPE strains, particularly in those carrying the blaOXA-48 gene. Resistance genes rmtF and aac(6')-Ib were identified on plasmids. These results highlight the need for careful monitoring of amikacin resistance.

Amikacin

[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].

Since 1981 we monitored all the bacteria strains isolated from patients bearing a surgical infection and hospitalized in our department. We also tested the susceptibility of the isolated strains to different antibiotics. The observed results at three different intervals (1981, 1984, 1987-1988) reveal an increase in Gram+strains. Among the tested antibiotics Imipenem and Amikacin showed the highest antibacterial activity in recent years (1987-1988).

Amikacin

[Bacteriology of neonatal septicemia in Dakar].

Between February 1983 and February 1991, 471 blood cultures from newborns with neonatal infection, aged from 0 to 30 days, admitted to the Pediatric Hospital Albert Royer, Dakar, were performed. In 141 (30.3 percent) cases, one bacterium was isolated. Three major causative organisms were identified: Klebsiella spp (28.6 percent), E. coli (19.5 percent) and S. aureus (17.4 percent). Altogether, we isolated 99 (69.2 percent) enterobacteria, 7 (4.8 percent) other Gram negative bacilli and 37 (25.8 percent) Gram positive cocci among which 25 S. aureus, 10 streptococci (7 group B, 2 group D, 1 group A and 2 pneumococci). The most efficient antibiotics were amikacin and third generation cephalosporins.

Amikacin